On March 14, 2019 Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, reported that Vipin K. Garg, Ph.D., President and Chief Executive Officer, and Will Brown, Acting Chief Financial Officer, will provide a corporate overview at the 31st Annual ROTH Conference (Press release, Altimmune, MAR 14, 2019, View Source [SID1234534322]). Details of the presentation are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

31st Annual ROTH Conference Presentation Details
Date: Tuesday, March 19
Time: 1:30pm Pacific Time
Location: The Ritz Carlton, Laguna Niguel in Orange County, CA